Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ3C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,498
Award facts
- Contract value 100% obligated
- $11,497.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,497.59 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Zepbound is a brand-name diabetes and weight management medication, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, and specialized medical commodities. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems in fulfilling critical pharmaceutical supply needs for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FCZ3C?
SPE2DR26FCZ3C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ3C worth?
The government has obligated $11,498 on SPE2DR26FCZ3C.
Is contract SPE2DR26FCZ3C an order under another contract?
Yes. SPE2DR26FCZ3C is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ3C competed?
The extent of competition for SPE2DR26FCZ3C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award